Curis (CRIS) Shareholder's Equity (2010 - 2026)
Curis (CRIS) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
502.95 Mn |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
12.71 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
12.71 Mn |
| Dec 31, 2025 |
5.46 Mn |
| Sep 30, 2025 |
-14.69 Mn |
| Jun 30, 2025 |
-13.99 Mn |
| Mar 31, 2025 |
-6.61 Mn |
| Dec 31, 2024 |
-6.00 Mn |
| Sep 30, 2024 |
-8.74 Mn |
| Jun 30, 2024 |
-694,000.00 |
| Mar 31, 2024 |
9.46 Mn |
| Dec 31, 2023 |
19.67 Mn |
| Sep 30, 2023 |
29.59 Mn |
| Jun 30, 2023 |
26.23 Mn |
| Mar 31, 2023 |
36.59 Mn |
| Dec 31, 2022 |
46.55 Mn |
| Sep 30, 2022 |
55.75 Mn |
| Jun 30, 2022 |
62.05 Mn |
| Mar 31, 2022 |
75.97 Mn |
| Dec 31, 2021 |
90.71 Mn |
| Sep 30, 2021 |
102.91 Mn |
| Jun 30, 2021 |
112.47 Mn |
